In a phase 1 study of 25 patients with hypoplastic left heart syndrome, autologous neonatal cardiac progenitor cells injected into the right ventricle at stage 2 surgery met safety and feasibility endpoints but did not improve right ventricular size or function.
RCTn = 25
Kaushal et al. Phase I Randomized Study of Cardiac Stem Cells in Patients With Hypoplastic Left Heart Syndrome: The CHILD Trial